Drugmakers under fire for possible U.S. price fixing

(Reuters) - Two prominent U.S. lawmakers on Thursday called on federal antitrust regulators to probe whether Sanofi SA , Eli Lilly and Co , Merck & Co Inc and Novo Nordisk A/S colluded to set prices for insulin and other diabetes drugs.

Drugmakers under fire for possible U.S. price fixing
Read More


Bagikan Berita Ini